SciELO - Scientific Electronic Library Online

 
vol.79 número2Acné y dieta: una revisión de los mecanismos patogénicosIngresos por COVID-19 en pediatría: experiencia en un hospital comarcal índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Boletín médico del Hospital Infantil de México

versión impresa ISSN 1665-1146

Bol. Med. Hosp. Infant. Mex. vol.79 no.2 México mar./abr. 2022  Epub 02-Mayo-2022

https://doi.org/10.24875/bmhim.21000075 

Research articles

COVID-19 in the pediatric population of the state of Jalisco: spatiotemporal analysis of 1,515 cases

COVID-19 en población pediátrica del estado de Jalisco: análisis espacio-temporal de 1,515 casos

Alberto Tlacuilo-Parra1  * 

Edwin Calderón-Vega1 

José de J. López-Jiménez2  3 

Leonardo Soto-Sumuano1  4 

Francisco Olivera-Guerrero4 

Elizabeth Guevara-Gutiérrez5 

1División de Investigación Médica, Unidad Médica de Alta Especialidad, Hospital de Pediatría, Centro Médico Nacional, Instituto Mexicano del Seguro Social, Mexico City

2División de Medicina Molecular, Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, Jalisco

3Departamento de Disciplinas Filosófico, Metodológico e Instrumentales, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco

4Departamento de Sistemas de Información, Centro Universitario de Ciencias Económico Administrativas, Universidad de Guadalajara, Guadalajara, Jalisco

5Departamento de Derrmatología, Instituto de Dermatología de Jalisco, Guadalajara, Jalisco. Mexico


Abstract

Background:

Initial publications of COVID-19 (2019 coronavirus disease) focused on the adult population until March 2020, when the first series in children was reported. Our objective was to analyze the spatiotemporal behavior of the pediatric population with COVID-19 in the state of Jalisco

Methods:

We conducted a cross-sectional study including subjects < 18 years of age with SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection confirmed by reverse transcription-polymerase chain reaction, registered in the RADAR platform. We investigated the prevalence, incidence rate, age, sex, outpatient or inpatient status, distribution of cases by time, municipality of residence, and geographical region. Descriptive statistics were used for data analysis

Results:

Of 58,231 subjects studied, 1,515 were children (3%): 768 males (51%) and 747 females (49%). The mean age was 12 ± 5 years; outpatients predominated (94%). The Central region concentrated the largest cases with 1,257 (82%) and was the second-highest incidence rate, behind the Occidental Coastal-Mountain region. The most affected municipality was Guadalajara. The distribution of new cases increased proportionally to mobility: after the holiday weekend in May, it rose from 28 to 161 cases; after the opening of beaches and recreational sites in June and July, to 539; and after the opening of movie theaters in August, to 673 cases

Conclusions:

Although with a lower incidence, the pediatric population is not exempt from SARS-CoV-2 infection. We observed an increase in cases as restrictions on social activities diminished.

Keywords COVID-19; SARS-CoV-2; Mexico; Pediatric; Epidemiology; Spatiotemporal analysis

Resumen

Introducción:

Las publicaciones iniciales de COVID-19 (enfermedad por coronavirus de 2019) se enfocaron en población adulta, hasta marzo de 2020, cuando se informó la primera serie en niños. Nuestro objetivo fue analizar el comportamiento espacio-temporal de la población pediátrica con COVID-19 en el estado de Jalisco.

Métodos:

Se llevó a cabo un estudio transversal en el que se incluyeron sujetos < 18 años con infección por SARS-CoV-2 (coronavirus tipo 2 del síndrome respiratorio agudo grave) confirmada por reacción en cadena de la polimerasa con retrotranscriptasa, registrados en la plataforma RADAR. Se investigó la prevalencia, tasa de incidencia, edad, sexo, paciente ambulatorio u hospitalizado, distribución de casos por tiempo, municipio de residencia y región geográfica. Se utilizó estadística descriptiva para el análisis de los datos

Resultados:

De 58,231 sujetos estudiados, se encontraron 1,515 pacientes pediátricos (3%): 768 de sexo masculino (51%) y 747 de sexo femenino (49%). La media de edad fue de 12 ± 5 años; predominaron los pacientes ambulatorios (94%). La región Centro concentró la mayor cantidad de casos con 1,257 (82%) y fue la segunda con mayor tasa de incidencia, detrás de la región Costa-Sierra Occidental. El municipio más afectado fue Guadalajara. La distribución de nuevos casos incrementó al aumentar la movilidad: después del puente vacacional de mayo subió de 28 a 161 casos; tras la apertura de playas y sitios de recreación en junio y julio, a 539 casos, y posterior a la apertura de cines en agosto, a 673 casos

Conclusiones:

Aunque con una incidencia menor, la población pediátrica no está exenta de la infección por SARS-CoV-2. Se observó un incremento de los casos a medida que disminuyeron las restricciones para las actividades sociales.

Palabras clave COVID-19; SARS-CoV-2; México; Pediátrico; Epidemiología; Análisis espacio-temporal

Introduction

The COVID-19 (coronavirus 2 disease) pandemic has established itself worldwide as the most significant public health challenge of the last 100 years. Although the first reports were made in adult populations, the novel SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) also affects the pediatric population, including newborns1-3.

Although children with COVID-19 generally do not present with severe symptoms, and up to 90% may be asymptomatic3-6, it is essential to investigate the behavior of the disease in this population. Based on available data, the pediatric population could play a key role in transmitting the virus, mainly due to its prolonged presence in nasal secretions and feces, which may facilitate its community dissemination in daycare centers, schools, and homes3,7,8.

No information was found on the epidemiological characteristics of patients < 18 years of age with confirmed SARS-CoV-2 infection in Jalisco nor data on the distribution by geographic region or monthly behavior during the pandemic. Therefore, the present study aimed to analyze the spatiotemporal behavior in pediatric patients with COVID-19 in Jalisco, Mexico.

Methods

Study design, source of information, and study period

We conducted a descriptive cross-sectional study from March 1 to September 27, 2020. Data on subjects with confirmed SARS-CoV-2 infection registered in the state of Jalisco, Mexico, were obtained from the official website of the Ministry of Health, Jalisco, through the Sistema RADAR Jalisco (Jalisco RADAR System) platform, which is an active epidemiological system for COVID-19 detection implemented by the state government in conjunction with the University of Guadalajara. Incidence rates were calculated per 100,000 inhabitants according to the National Institute of Statistics and Geography (INEGI for its Spanish acronym) latest census9.

Selection criteria

We included individuals ≤ 18 years of age, residents of Jalisco, who met the definition of a confirmed case of SARS-CoV-2 infection. A confirmed case was established as a subject of any age who 7 days prior had presented at least two of the following signs or symptoms: cough, fever, headache (in children < 5 years of age, irritability instead); and at least one of the following signs or symptoms: respiratory distress, arthralgia, muscle pain, odynophagia, rhinorrhea, conjunctivitis, chest pain. Also, a positive result in the real-time retrotranscription polymerase chain reaction (RT-PCR) test for SARS-CoV-2, performed in the National Network of Public Health Laboratories, which are recognized by the Institute of Epidemiological Diagnosis and Reference (InDRE for its Spanish acronym)10-12.

Study variables and definitions

HEALTH STATUS

Patient health status was divided into ambulatory (outpatient) and hospitalized (inpatient) when the confirmed case was captured.

SPATIAL DISTRIBUTION

The distribution of cases in the 12 geographic regions that make up the state of Jalisco: North, Highlands North, Highlands South, Marshland, Southeast, South, Amula Mountains, Coastal South, Occidental Coastal-Mountain, Valleys, Lagoons, and Central, including 125 municipalities.

TEMPORAL DISTRIBUTION

The information of each individual captured in the Sistema RADAR Jalisco platform was divided by month.

Statistical analysis

Data capture and processing were performed using Microsoft Office Excel® software 2013 (Microsoft Corp., Redmond, WA) IBM®SPSS Statistics for Windows v22 (IBM Corp., Armonk, NY). The Kolmogorov-Smirnov test was used to determine the type of distribution of the groups analyzed. Descriptive statistics were used to determine averages and percentages according to every statistical variable. The χ2 test was used to compare qualitative variables, and the Student’s t-test was used for the quantitative variables. A value of p < 0.05 was considered statistically significant.

Temporary milestones and control measures

The first case of COVID-19 in Mexico was detected on February 27, 2020, in Mexico City. On February 28, two additional cases were confirmed, resulting in the declaration of COVID Phase 1; that is, the scenario in which the cases were imported from abroad, and there was no local contagion or spread. On March 11, the World Health Organization declared the COVID-19 pandemic. On March 14, 2020, the Ministry of Public Education (Secretaría de Educación, Mexico) changed the Easter vacations and extended them to one month (from March 23 to April 20) for all educational institutions nationwide13.

Following the first local infections, the federal government declared Phase 2 on March 24. Some economic activities were suspended; large gatherings were restricted, and it was recommended to stay at home, especially for individuals > 60 years. As of March 26, all non-essential federal government activities were suspended, except those related to security, health, energy, and sanitation. Sneezing into the elbow was recommended, along with frequent hand washing and continuous cleaning and disinfecting of high-use public areas. Persons with symptoms and confirmation of COVID-19 should wear facial masks13.

Due to the evolution of confirmed cases and deaths, a national public health emergency was declared on March 30. The immediate suspension of all non-essential activities in all economic sectors of the country was proclaimed for one month (until April 30). Subsequently, due to evidence of active outbreaks and spread of the virus with more than 1000 cases, phase 3 was initiated on April 21, 2020, which brought with it measures such as the suspension of non-essential activities in the public, private, and social sectors, and the extension of the National Safe Healthy Distance Guidelines until May 3013,14.

Ethical aspects

The local Research and Ethics Committee approved the present study (Instituto Mexicano del Seguro Social registration number CLIS R-2020-1302-031). The study was conducted based on the Ethical Standards and Guidelines for Research Involving Human Beings established by the Declaration of Helsinki (Fortaleza, Brazil, 2013). Following good clinical practice, the confidentiality of the participants was protected: at no time were they identified by name, and they were assigned a code to protect their anonymity.

Results

From March 1 to September 27, 2020, 58,231 positive cases of SARS-CoV-2 infection were detected in Jalisco. Among them, the pediatric population corresponded to 1,515 patients (prevalence of 3%): the mean age was 12 ± 5 years (range 0-18 years), with a predominance of males (n = 768; 51%), and a higher prevalence of ambulatory patients (n = 1,427; 94%). When comparing the epidemiological characteristics and health status of the pediatric population with the adult population, we found a statistically significant difference in age (12 vs. 43 years, p = 0.001, Student t-test) and in the percentage of hospitalizations (6% vs. 14%, p = 0.001, χ2 test).

According to age distribution in individuals ≤ 18 years, we found that SARS-CoV-2 infection predominated in adolescents aged 15 to 18 years (n = 738; 49%). The prevalence gradually decreased the younger the age of the patients, so that the least affected group was infants < 1 year of age (n = 48; 3%). In this group, we found a slight predominance of the males with a male-female ratio of 1.28:1. This ratio decreased in the older age groups since both sexes were affected almost equally in the 15 to 18 years group, with a male-female ratio of 0.96:1. The percentage of ambulatory to hospitalized patients was lower in the < 1 year of age group than the 15-18 years of age group (1.4:1 vs. 45.12:1) (Table 1).

Table 1 Epidemiological characteristics of patients with SARS-CoV-2 infection in Jalisco distributed by age (n = 58,231) 

Variable < 1 year (n = 48) 1-4 years (n = 156) 5-9 years (n = 205) 10-14 years n = 368) 15-18 years (n = 738) > 18 years (n = 56,716)
Sex
Male, n (%) 27 (56) 89 (57) 112 (55) 178 (48) 362 (49) 28,923 (51)
Female, n (%) 21 (44) 67 (43) 93 (45) 190 (51) 376 (51) 27,793 (49)
Ratio M:F 1.28:1 1.32:1 1.20:1 0.93:1 0.96:1 1.04:1
Age in years
Mean ± SD 2.2 ± 1.1 6.9 ± 1.4 12.4 ± 1.3 16.8 ± 1.1 43 ± 15
Health status
Ambulatory, n (%) 28 (58.3) 140 (89.7) 188 (91.7) 349 (94.8) 722 (97.8) 48,864 (86)
Hospitalized, n (%) 20 (41.6) 16 (10.2) 17 (8.2) 19 (5.1) 16 (2.1) 7,852 (14)
Ratio A:H 1.4:1 8.75:1 11.05:1 18.36:1 45.12:1 6.22:1

A, ambulatory; F, female; H, hospitalized; M, male; SD, standard deviation.

The spatial distribution of pediatric patients with SARS-CoV-2 (n = 1,434; 95%) was concentrated in five geographic regions: Central (n = 1,257; 83%), Occidental Coastal-Mountain (n = 58; 4%), Highlands South (n = 50; 3%), Highlands North (n = 37; 2.4%), and Marshland (n = 32; 2.1%); the Coastal South region recorded no cases. This spatial distribution by geographic area was similar to that observed in the > 18 years age group, where four of the five regions had a higher number of cases (n = 51,350; 91%) (Table 2). When evaluating the location of the five geographic regions with the most pediatric patients, we found that they were predominately located in the northern part of Jalisco. The Northern region, which is not among the areas with the highest frequency of cases, ranked third in incidence rate, with 148 cases per 100,000 inhabitants, and is located in the northern part of Jalisco (Figure 1).

Table 2 Spatial distribution by geographical region of patients with SARS-CoV-2 infection in Jalisco (n = 58,231) 

Number Region ≤ 18 years (n = 1,515) > 18 years (n = 56,716)
n (%) Incidence rate* n (%) Incidence rate*
1 North 12 (1) 148 157 (0.2) 1,930
2 Highlands North 37 (2.4) 89 958 (2) 2,293
3 Highlands South 50 (3) 122 915 (2) 2,224
4 Marshland 32 (2.1) 94 1,265 (2) 3,731
5 Southeast 9 (0.5) 77 288 (0.5) 2,469
6 South 30 (2) 81 1,753 (3) 4,715
7 Amula Mountains 9 (0.5) 90 498 (0.8) 5,003
8 Coastal South 0 (0) 0 317 (0.5) 1,775
9 Occidental Coastal-Mountain 58 (4) 942 3,049 (5) 49,502
10 Valleys 13 (1) 34 909 (2) 2,365
11 Lagoons 8 (0.5) 14 529 (1) 955
12 Central 1,257 (83) 236 46,078 (81) 8,647

*Incidence rate per 100,000 inhabitants.

In the < 18 years age group, four of the five geographic regions with the highest number of cases corresponded to those with the highest incidence rates: Occidental Coastal-Mountain, Central, Highlands South, and Marshland. Similarly, in the > 18 years age group, four regions with the highest frequency of cases also had the highest incidence rates: Occidental Coastal-Mountain, Central, Marshland, and South.

Figure 1 The Central, Occidental Coastal-Mountain, Highlands North, and Marshland regions (top half of the map) are among the top five locations with the highest cases in both age groups. 

The greatest number of cases was concentrated in the central region, both in the pediatric (n = 1,257; 83%) and adult (n = 46,078; 81%) populations. This region had the second-highest incidence rate in the entire state: 236 cases per 100,000 inhabitants in the pediatric population and 8,647 cases per 100,000 inhabitants in the adult population; it ranked only behind the Occidental Coastal-Mountain region where incidence rates were 942 cases per 100,000 inhabitants and 49,502 cases per 100,000 inhabitants, respectively (Table 2). Of the 12 municipalities that comprise the Central region, the five with the highest numbers of individuals infected with SARS-CoV-2 were Guadalajara, Zapopan, Tlaquepaque, Tlajomulco de Zúñiga, and Tonalá, where we detected 1,224 (81%) patients ≤ 18 years of age and 44,774 (79%) > 18 years (Table 3). Other municipalities with a high number of pediatric cases were Puerto Vallarta, with 53 cases (3%) and 18 cases per 100,000 inhabitants; Tepatitlán, with 30 cases (2%) and 20 cases per 100,000 inhabitants; and San Juan de los Lagos, with 18 cases (1%) and 25 cases per 100,000 inhabitants.

Table 3 Five municipalities with highest numbers of cases with SARS-CoV-2 infection in Jalisco distributed by age groups (n = 58,231) 

Region ≤ 18 years (n = 1,515) > 18 years (n = 56,716)
n (%) Incidence rate* n (%) Incidence rate*
Guadalajara 486 (32) 35 20,851 (37) 1,505
Zapopan 453 (30) 31 13,225 (23) 896
Tlaquepaque 112 (7) 16 4,300 (7.5) 626
Tlajomulco de Zúñiga 100 (7) 14 3,267 (6) 449
Tonalá 73 (5) 13 3,131 (5.5) 549

*Incidence rate per 100,000 inhabitants.

When addressing the temporal distribution of pediatric patients with COVID-19 in these five municipalities, we observed an increase in the number of cases starting in the second two-month period of the study since 17 cases were detected between March-April. In contrast, the number increased to 311 in May-June. Finally, in the last quarter of the study period, 896 cases were identified; the highest number of cases occurred in August (353 patients) (Table 4).

Table 4 Temporal behavior of the numbers of cases ≤ 18 years of age with SARS-CoV-2 infection in the five most affected municipalities in Jalisco (n = 1,224) 

Municipality March April May June July August September Total
Guadalajara 3 8 44 100 113 133 85 486
Zapopan 0 1 26 65 114 149 98 453
Tlaquepaque 1 1 16 14 40 24 16 112
Tlajomulco 0 0 12 17 31 29 11 100
Tonalá 1 2 9 8 18 18 17 73
Total 5 12 107 204 316 353 227 1,224

When evaluating the temporal distribution of pediatric cases according to the health measures adopted by the state government, we observed that social isolation and the suspension of in-person classes decreased the number of cases from seven to two and that the closure of non-essential commercial centers and the mandatory use of facial masks allowed a slight increase of only 19 patients in one month. In contrast, with the decrease in the strictness of these measures due to festivities or holidays, the number of cases increased exponentially: in May, after the Labor Day long weekend, the number of patients increased to 161 (eight times more than those recorded the previous month); in June, the opening of beaches, hot springs, water parks, and zoos was associated with an increase of 539 cases in the 50 days (Table 5).

Table 5 Patients with SARS-CoV-2 infection distributed according to measures adopted by the government of the state of Jalisco (n = 58,231) 

Period Actions ≤ 18 years (n = 1,515) > 18 years (n = 56,716)
01/03 to 13/03 Day zero
Before the onset of measures
7 217
14/03 to 01/04 March 13
Social isolation
2 121
March 17
Suspension of in-person classes
2/04 to 20/04 April 01
Closure of non-essential commercial centers
9 390
21/04 to 01/05 April 20
Obligatory use of facial masks
10 359
2/05 to 31/05 May 03
Preventive measures are decreased (long-weekend?)
161* 4,011**
1/06 to 11/06 June 01
Opening of non-essential businesses at 50% capacity
87 4,066
12/06 to 15/06 June 11
Declaration of Individual Responsibility
27 1,439
16/06 to 20/07 June 15
Opening of beaches
353*** 15,441***
21/07 to 04/08 July 20
Opening of hot springs, water parks, zoos
186*** 7,683***
05/08 to 27/09 August 06
Open cinemas and casinos
673 22,989

*In individuals ≤ 18 years, there were 55 cases from May 2-14 and 106 from May 15-31 (14 days after the May long weekend).

**In individuals > 18 years, there were 915 cases from May 2-14 and 3,096 from May 15-31.

***The opening of beaches, hot springs, water parks, and zoos brought about 539 new cases in individuals ≤ 18 years and 23,124 new cases in those > 18 years of age.

Discussion

Research related to the epidemiological behavior of SARS-CoV-2, especially in pediatric age groups, is scarce. In our study, the prevalence of SARS-CoV-2 infection in children and adolescents was 3%, similar to the 3.9% reported by the Dirección de Información Epidemiológica in subjects under 20 years of age nationwide15, but higher than that reported in China—with 2% of positive cases in individuals under 19 years of age—and Italy with 1.2%3,4. However, these rates could be higher, as asymptomatic infections are known to occur in the pediatric population. In China, for example, up to 13% of virologically confirmed cases are considered to have an asymptomatic infection; that is, many children without symptoms are not evaluated4.

Regarding age at presentation, we found a mean age of 12 years. In contrast, Dong et al. found a mean age of 7 years4. Other countries also report lower mean ages than the pediatric population of Jalisco: 6 years in India, 7 years in Morocco, and 8 years in the United States16-18. While in these other countries, school-age children predominate, we found in our population that almost half of the subjects were adolescents (15-18 years of age) with a prevalence of 49%. This difference could be explained because we included ambulatory and hospitalized patients, whereas the approach in other countries considered only patients requiring hospitalization. In our study, 94% of the pediatric population was ambulatory.

Furthermore, we found a slight predominance of males (51% of cases), a lower prevalence than that reported in the pediatric population in China (56.6% males) and Mexico City (59% males). However, in both studies, the difference regarding sex was not significant4,19.

Regarding the health status of the subjects included in the present study, we found 16.2 ambulatory patients for every hospitalized one patient in the group ≤ 18 years of age, whereas this ratio diminished to 6.2 ambulatory patients for every hospitalized one patient in the group >18 years, which was a statistically significant difference. This finding supports what has already been observed: the pediatric population presents less severe clinical conditions that allow ambulatory treatment3, while the prognosis is worse in the adult population, partly due to comorbidities that make them more susceptible to developing complications and being hospitalized20.

The ratio of pediatric ambulatory patients to hospitalized patients varied among age groups. We found that most hospitalizations occurred in the < 1-year-old group, where for every 1.4 ambulatory individuals, one was hospitalized (almost a 1:1 ratio). Conversely, this ratio increased proportionally with age, so that in the 15-18 years-old group, there were 45.1 ambulatory patients for every hospitalized one.

Regarding spatial distribution, it was interesting to note that four of the five geographic regions with the highest number of cases (Central, Occidental Coastal-Mountain, Highlands North, and Marshland) are located in northern Jalisco. We do not know whether environmental conditions in these areas, such as air pollution, environmental degradation, climate, or temperature factors, may facilitate infection or modify virus survival, as mentioned in a previous publication21. In any case, this finding could be the basis for future research.

When analyzing the number of individuals with COVID-19 by geographic region, we found that most of the confirmed cases were concentrated in the Central area: 83% of patients in the pediatric population and 81% in the adult population. This is an expected finding if we consider that the Central region includes the municipalities of Guadalajara, Zapopan, Tlaquepaque, Tlajomulco de Zúñiga, and Tonalá where 81% of our pediatric patients were concentrated. These high percentages could be attributed to the higher population density than other municipalities in the state. According to the latest INEGI9 census, Guadalajara has 10,361 inhabitants/km2, while the mean population density for the state is 100 inhabitants/km2. Therefore, the higher the population density, the greater transmissibility of the virus.

The Occidental Coastal-Mountain (4%) and Highlands South (3%) regions followed the Central area in positive cases in the pediatric population. Although they do not have the population density of the Guadalajara metropolitan area, these regions include the municipalities of Puerto Vallarta, Tepatitlán de Morelos, and San Juan de los Lagos. These municipalities have a high urban concentration during part of the year due to recreational, commercial, and religious tourism22.

As expected, the number of cases increased exponentially at the onset of the community spread phase regarding the temporal distribution of cases. However, we should emphasize that the infection peaks were related to reducing sanitation measures to prevent it23. For example, between May 2 and May 14, 55 cases were confirmed in ≤ 18 years, and 915 in > 18 years; however, between May 15 and May 31, 14 days after the Labor Day holiday (May 1), rates rose to 106 cases (almost double) in < 18 years, while they tripled in those >18 years of age with 3,096 patients.

Similarly, on June 1, non-essential commercial activities returned to 50% of their standard capacity in the state of Jalisco23. Unfortunately, this opening resulted in the reporting of 5,619 new cases in the first 15 days of the month alone, when the total number of positive cases reported in March, April, and May were 5,287. Although this increase was mainly at the expense of the adult population, pediatric patients were not exempt since, in those 15 days, 114 new cases were registered; that is, 60.3% more than previously recorded in this population.

Finally, in July, following the reopening of recreational aereas23 such as beaches, hot springs, water parks, and zoos, 539 cases were recorded in <18-year-old and 23,124 in those >18 years; while in August, with the opening of cinema theatres and casinos23, the highest rates observed in our study were registered, with 673 new cases in the pediatric population and 22,989 in adults.

Due to the nature of the database contained in the Sistema RADAR Jalisco platform, this study has several limitations: the clinical presentation of the disease is unknown; the patients included belong to an anonymous database, so neither their treatments nor their results were available; there is no follow-up of the individuals included, so the clinical evolution, vital status, prognosis, and variables that may affect them are unknown; finally, the information is from a single state, so the results cannot be generalized to the rest of the country. Despite these limitations, our series is more extensive than that reported for the state of Sinaloa (51 patients)24 and for Mexico City (510 patients)19, which allows us to contribute essential data of interest that have not been published previously, and that can guide us on the epidemiological and spatiotemporal behavior of pediatric patients with COVID-19 in the state of Jalisco.

References

1. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395:470-3. [ Links ]

2. Paules CI, Marston HD, Fauci AS. Coronavirus infections—more than just the common cold. JAMA. 2020;323:707-8. [ Links ]

3. Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109:1088-95. [ Links ]

4. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145:e20200702. [ Links ]

5. Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents:a systematic review. JAMA Pediatr. 2020;174:882-9. [ Links ]

6. Liguoro I, Pilotto C, Bonanni M, Ferrari ME, Pusiol A, Nocerino A, et al. SARS-COV-2 infection in children and newborns:a systematic review. Eur J Pediatr. 2020;179:1029-46. [ Links ]

7. Jiehao C, Jin X, Daojiong L, Zhi Y, Lei X, Zhenghai Q, et al. A case series of children with 2019 novel coronavirus infection:clinical and epidemiological features. Clin Infect Dis. 2020;71:1547-51. [ Links ]

8. Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158:1831-33.e3. [ Links ]

9. Instituto Nacional de Estadística y Geografía. Censo de Población y Vivienda 2020. Principales resultados por localidad (ITER) 2020. Jalisco (accessed:30-09-2021). INEGI;2021. Available from:https://www.inegi.org.mx/app/scitel/Default?ev=9 [ Links ]

10. Gobierno de México. Diario Oficial de la Federación. Norma Oficial Mexicana NOM-017-SSA2-2012 para la vigilancia epidemiológica. (accessed:08-04-2021). Mexico:Secretaría de Gobernación. Estados Unidos Mexicanos;2021. Available from:http://dof.gob.mx/nota_detalle.php?codigo=5288225&fecha=19/02/2013 [ Links ]

11. Gobierno de México. Secretaría de Salud. Lineamiento estandarizado para la vigilancia epidemiológica y por laboratorio de enfermedad por COVID-19. (accessed:08-04-2021). Mexico:Secretaría de Salud. Subsecretaría de Prevención y Promoción de la Salud. Dirección General de Epidemiología;2021. Available from:https://www.gob.mx/salud/documentos/lineamiento-estandarizado-para-la-vigilancia-epidemiologica-y-por-laboratorio-de-la-enfermedad-respiratoria-viral [ Links ]

12. Instituto Mexicano del Seguro Social. Educación en Salud. COVID-19 Portal de la Coordinación de Educación en Salud. (accessed:08-04-2021). Mexico:Educación en Salud IMSS;2021. Available from:http://educacionensalud.imss.gob.mx/es/coronavirus [ Links ]

13. Gobierno de México. Secretaría de Salud. Casos confirmados a enfermedad por COVID-19. (accessed:08-04-2021). Mexico:SSA;2021. Available from:https://www.gob.mx/salud/documentos/coronavirus-covid-19-comunicado tecnicodiario-238449 [ Links ]

14. Gobierno de México. Inicia la fase 3 por COVID-19. (accessed:08-04-2021). Mexico:Secretaría de Salud (SSA);2020. Available from:https://coronavirus.gob.mx/2020/04/21/inicia-la-fase-3-por-covid-19-2/ [ Links ]

15. Gobierno de México. Dirección de Información Epidemiológica. Análisis epidemiológico de COVID-19 en niños y adolescentes. Mexico:Secretaría de Salud. Subsecretaría de Prevención y Promoción de la Salud. Dirección General de Epidemiología;2020. Available from:www.gob.mx/salud [ Links ]

16. Sarangi B, Reddy VS, Oswal JS, Malshe N, Patil A, Chakraborty M, et al. Epidemiological and clinical characteristics of COVID-19 in Indian children in the initial phase of the pandemic. Indian Pediatr. 2020;57:914-7. [ Links ]

17. Fakiri KE, Nassih H, Sab IA, Draiss G, Bouskraoui M. Epidemiology and clinical features of coronavirus disease 2019 in Moroccan children. Indian Pediatr. 2020;57:808-10. [ Links ]

18. Kim L, Whitaker M, O'Halloran A, Kambhampati A, Chai SJ, Reingold A, et al. Hospitalization rates and characteristics of children aged <18 years hospitalized with laboratory-confirmed COVID-19—COVID-NET, 14 States, March 1-July 25, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1081-8. [ Links ]

19. Olivar-López V, Leyva-Barrera A, López-Martínez B, Parra-Ortega I, Márquez-González H. Clinical risk profile associated with SARS-CoV-2 infection and complications in the emergency area of a pediatric COVID-19 center. Bol Med Hosp Infant Mex. 2020;77:221-7. [ Links ]

20. Ortiz-Brizuela E, Villanueva-Reza M, Gonzalez-Lara MF, Tamez-Torres KM, Román-Montes CM, Díaz-Mejía BA, et al. Clinical and epidemiological characteristics of patients diagnosed with COVID-19 in a tertiary care center in Mexico City:a prospective cohort study. Rev Invest Clin. 2020;72:252-8. [ Links ]

21. Shakil MH, Munim ZH, Tasnia M, Sarowar S. COVID-19 and the environment:a critical review and research agenda. Sci Total Environ. 2020;745:141022. [ Links ]

22. Radar Jalisco. Mapa de casos de COVID-19 en Jalisco. (accessed:08-04-2021). Mexico:Sistema de Detección Activa COVID-19;2021. Available from:https://coronavirus.jalisco.gob.mx/mapa-de-casos [ Links ]

23. Radar Jalisco. Comparativo de casos confirmados en Jalisco. Corte del día. (accessed:08-04-2021). Mexico:Sistema de detección activa COVID-19;2021. Available from:https://coronavirus.jalisco.gob.mx/corte-del-dia [ Links ]

24. Pérez-Gaxiola G, Flores-Rocha R, Valadez-Vidarte JC, Hernández-Alcaraz M, Herrera-Mendoza G, Real-Lugo MAD. Clinical and epidemiological characteristics of children with SARS-CoV-2 infection:a case series in Sinaloa. Bol Med Hosp Infant Mex. 2021;78:18-23. [ Links ]

Ethical disclosures

Protection of human and animal subjects. The authors declare that no experiments were performed on humans or animals for this study.

Confidentiality of data. The authors declare that they have followed the protocols of their work center on the publication of patient data.

Right to privacy and informed consent. The authors have obtained the written informed consent of the patients or subjects mentioned in the article. The corresponding author has this document.

FundingNone.

Received: April 20, 2021; Accepted: October 08, 2021

* Correspondence: Alberto Tlacuilo Parra E-mail: jose.tlacuilo@imss.gob.mx:

Conflicts of interest

The authors declare no conflict of interest.

Creative Commons License Instituto Nacional de Cardiología Ignacio Chávez. Published by Permanyer. This is an open ccess article under the CC BY-NC-ND license